The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma.
BJUI compass（2022）
摘要
We observed 38% of the trial eligible population. Overall survival was significantly different between the trial eligible and ineligible groups.
更多查看译文
关键词
chemotherapy,maintenance immunotherapy,prognosis,radiological response,urothelial carcinoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要